A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer
NCT05735080 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Incyclix Bio. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Incyclix Bio.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Incyclix Bio currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Incyclix Bio conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Incyclix Bio currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.